Paxlovid

Postexposure Prophylaxis With Nirmatrelvir-Ritonavir Does Not Cut COVID-19 Infection

Postexposure Prophylaxis With Nirmatrelvir-Ritonavir Does Not Cut COVID-19 Infection

Jul 18, 2024

1 min read

Nirmatrelvir-Ritonavir No Aid for Long COVID Symptoms

Nirmatrelvir-Ritonavir No Aid for Long COVID Symptoms

Jun 10, 2024

2 min read

Extended Course of Paxlovid Adds No Benefit for Those With Long COVID

Infectious Disease

Extended Course of Paxlovid Adds No Benefit for Those With Long COVID

Dennis Thompson

Jun 07, 2024

3 min read

Meds Rarely Offered for COVID-19 Patients at High Risk for Progression

Meds Rarely Offered for COVID-19 Patients at High Risk for Progression

Jan 25, 2024

1 min read

Nirmatrelvir During Acute SARS-CoV-2 Does Not Reduce Risk for Long COVID

Nirmatrelvir During Acute SARS-CoV-2 Does Not Reduce Risk for Long COVID

Jan 05, 2024

1 min read

Virologic Rebound Occurs in ~20 Percent Receiving Nirmatrelvir-Ritonavir

Virologic Rebound Occurs in ~20 Percent Receiving Nirmatrelvir-Ritonavir

Nov 14, 2023

1 min read

Taking Paxlovid Probably Won’t Protect You from Long COVID

Infectious Disease

Taking Paxlovid Probably Won’t Protect You from Long COVID

Oct 31, 2023

1 min read

www.healthday.com